文献速递肾移植

活体肾捐献后健康相关生活质量:系统综述与荟萃分析

Health-Related Quality of Life After Living Kidney Donation: A Systematic Review and Meta-Analysis.
PubMed 文献 · Am J Kidney Dis · 2025-11-12

该研究纳入73项研究、14,474名活体肾捐献者,评估捐献后健康相关生活质量。结果显示捐献后3个月躯体健康评分显著低于捐献前,但6个月时恢复至捐献前水平;精神健康评分无显著变化;捐献者生活质量显著高于一般人群和健康对照。

要点

  • 活体肾捐献后3个月躯体健康评分较术前下降,6个月时恢复至术前水平。
  • 捐献后精神健康评分在3、6、12个月均无显著变化。
  • 捐献者生活质量显著优于一般人群、健康对照、受者及透析患者。

核心结论

  • 活体肾捐献后躯体健康相关生活质量在3个月时下降,但6个月内恢复至捐献前水平。
  • 捐献者报告的健康相关生活质量显著优于一般人群和健康对照。
  • 对捐献后生活质量的担忧不应成为阻碍潜在活体肾捐献者的因素。

研究设计与样本

  • 系统综述与荟萃分析,纳入73项研究共14,474名活体肾捐献者。
  • 检索Embase、MEDLINE OvidSP、CENTRAL、Web of Science、PsycINFO及Google Scholar前100名。
  • 采用PRISMA指南提取数据,随机效应模型(限制性最大似然法)合并效应量。

主要发现

  • 捐献后3个月躯体健康评分(PCS)显著低于捐献前,标准化均数差-0.38(95%CI -0.72至-0.05,P=0.02)。
  • PCS在6个月和12个月时与捐献前无显著差异。
  • 精神健康评分(MCS)在3、6、12个月及以上与基线相比无显著变化。
  • 捐献者PCS和MCS评分均显著高于一般人群。
  • 捐献者生活质量与健康对照、受者、肾切除患者及维持性透析患者相当或更优。

关键数值与推荐

  • 主要结局为SF-36量表及其心理成分总结(MCS)和躯体成分总结(PCS)。
  • 比较捐献后与捐献前生活质量,以及与一般人群的生活质量。
  • 研究水平效应以连续变量的标准化均数差表示。

临床怎么用

  • 可向潜在活体肾捐献者说明:捐献后躯体生活质量短暂下降但6个月内恢复。
  • 捐献者长期精神健康相关生活质量无显著受损。
  • 捐献者整体生活质量优于一般人群及多种对照人群。

局限性

  • 研究人群和结局存在异质性。
  • 某些比较的研究数量有限。
  • 尤其较老的研究存在方法学缺陷。
  • 研究地域分布存在变异性。
  • 未能校正时间变化的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE & OBJECTIVE: Living donor kidney transplantation is considered the most effective treatment for end-stage kidney disease, but healthy individuals who donate may experience potential threats to their long-term well-being. This meta-analysis assessed the impact of living kidney donation on health-related quality of life (HRQoL) among donors overall and among those at higher risk for negative health impacts. STUDY DESIGN: Systematic review and meta-analysis. SETTING & PARTICIPANTS: Living donors of kidney allografts included in studies of postdonation HRQoL with predefined inclusion and exclusion criteria. Studies were identified through a comprehensive search of Embase, MEDLINE OvidSP, CENTRAL, Web of Science, PsycINFO, and the top 100 rankings in Google Scholar. DATA EXTRACTION: Data were extracted in accordance with PRISMA guidelines, with independent extraction by multiple observers to ensure accuracy. ANALYTICAL APPROACH: Primary outcomes included the 36-item Short-Form Health Survey (SF-36) and its composite mental component summary (MCS) and physical component summary (PCS). These measures were used to compare postdonation HRQoL with predonation levels and to the HRQoL of the general population. Study-level effects were calculated as standardized mean differences for continuous variables. Pooled effects were estimated with a random-effects model using restricted maximum likelihood. RESULTS: The meta-analysis included 73 studies with 14,474 donors. The MCS did not show significant changes at 3, 6, or 12 or more months after donation compared with baseline. However, the PCS was significantly lower at 3 months after donation compared with before donation (standardized mean difference, -0.38 [95% CI, -0.72 to -0.05], P = 0.02), which did not persist at 6 or 12 months. Both PCS and MCS scores were significantly higher in donors than in the general population. Donors' HRQoL scores were comparable to or better than those of healthy controls, recipients, patients who underwent a nephrectomy, and patients receiving maintenance dialysis. LIMITATIONS: Heterogeneity in study populations and outcomes, a limited number of studies for certain comparisons, methodological weaknesses of especially older studies, variability across geographies studied, and unaccounted for temporal changes. CONCLUSIONS: Kidney donors reported physical HRQoL to be decreased after living donor nephrectomy, which returned to predonation levels by 6 months. The HRQoL reported by living donors was significantly better than that of the general population and healthy controls. These findings suggest that concerns about postdonation HRQoL need not be a deterrent to potential living kidney donors. TRIAL REGISTRATION: Registered at PROSPERO with study number CRD42024540202. PLAIN-LANGUAGE SUMMARY: This study examined the well-being of living kidney donors after donation by summarizing the findings of 73 studies, which included more than 14,000 donors. Overall, the donors' quality of life remained high. Their physical health was slightly lower 3 months after donation but returned to predonation levels shortly afterward. Their quality of life related to mental health remained unchanged after donation. Donors generally experienced health comparable to or better than that of the general population and other patient groups. Certain factors, such as complications or stress related to the recipient's condition, may temporarily have affected donors' well-being, but most recovered fully within a year. These findings may reassure potential donors that kidney donation does not typically have long-term negative effects on their health.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. van de Laar SC, de Heus HA, Massey EK, et al. Health-Related Quality of Life After Living Kidney Donation: A Systematic Review and Meta-Analysis. Am J Kidney Dis. 2025. PMID: 41238161. doi:10.1053/j.ajkd.2025.09.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。